Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1984 Oct;18(4):481-5.
doi: 10.1111/j.1365-2125.1984.tb02495.x.

The role of sulphate conjugation in the metabolism and disposition of oral and intravenous paracetamol in man

The role of sulphate conjugation in the metabolism and disposition of oral and intravenous paracetamol in man

J A Clements et al. Br J Clin Pharmacol. 1984 Oct.

Abstract

The effects of paracetamol dose (5 and 20 mg/kg) and route of administration (intravenous and oral) on the urinary excretion of paracetamol and its glucuronide, sulphate, cysteine and mercapturic acid conjugates were studied in five healthy subjects. The fractional urinary excretion of unchanged paracetamol and its conjugates was independent of the route of administration at both dose levels, suggesting that the gastrointestinal tract is not an important site for paracetamol metabolism. The percentage of the dose excreted as the sulphate conjugate was significantly higher after 5 than after 20 mg/kg (37.7% and 33.3% respectively) and this is consistent with saturation of sulphate conjugation. No significant effect of paracetamol dose upon the area under the plasma concentration-time curve (AUC), corrected for dose, was found for the sulphate or glucuronide conjugates. The total plasma clearance of paracetamol and the renal clearance of the sulphate conjugate were significantly higher after the 5 than the 20 mg/kg dose (331 +/- 42 ml/min and 295 +/- 48 ml/min; 273 +/- 74 ml/min and 205 +/- 46 ml/min respectively). The oral systemic availability of paracetamol was 80% and independent of dose.

PubMed Disclaimer

References

    1. J Pharm Sci. 1971 Feb;60(2):215-21 - PubMed
    1. Br J Pharmacol. 1972 Nov;46(3):458-72 - PubMed
    1. J Pharm Pharmacol. 1974 Apr;26(4):265-7 - PubMed
    1. Xenobiotica. 1974 Jun;4(6):345-53 - PubMed
    1. Eur J Clin Pharmacol. 1977 Apr 20;11(4):283-6 - PubMed

LinkOut - more resources